X-chem, INC.:1371178 [23-004735]
Ended Purchase Order Awarded Last action
- Contract number
- 75N95023P00317
- Awardee
-
X-Chem, Inc. UEI TEYFWDKJ48Y7
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,785,000
Award facts
- Contract value 100% obligated
- $1,785,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Waltham, MA 02453, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $45,000 | |
| Original award | $1,740,000 |
About this award
The National Center for Advancing Translational Sciences (NCATS), a civilian agency within the Department of Health and Human Services, has awarded a $1,785,000.00 firm fixed price purchase order contract to X-Chem, Inc., a for-profit drug discovery company. The 8-month contract, which runs from May 2023 through January 2024, does not have a set-aside designation. Based on X-Chem's prior work as a subcontractor on federal grants focused on early-stage drug discovery research, the contract likely involves using X-Chem's proprietary screening platform to identify and optimize small molecule inhibitors against biological targets of interest. No additional details on the specific products or services being provided were included in the award information.
Quick answers
Who was awarded contract 75N95023P00317?
75N95023P00317 was awarded to X-Chem, Inc. by National Institute on Drug Abuse (National Institutes of Health) on May 30, 2023.
How much is contract 75N95023P00317 worth?
The government has obligated $1,785,000 on 75N95023P00317.
Which agency awarded contract 75N95023P00317?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95023P00317, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Was contract 75N95023P00317 competed?
The extent of competition for 75N95023P00317 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award